Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 35 OTHER 7 NIH 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non Small Cell Lung Cancer Metastatic 1

Interventions

Radiotherapy 87 Cyclophosphamide 84 Cisplatin 79 Doxorubicin 66 Vincristine 62 Paclitaxel 55 Etoposide 50 Carboplatin 49 Filgrastim 48 Methotrexate 41 Prednisone 40 Cytarabine 37 Granulocyte Colony-Stimulating Factor 35 Radiotherapy, Intensity-Modulated 31 Platinum 31 Docetaxel 31 Gemcitabine 30 Leucovorin 28 Dexamethasone 28 Radiotherapy, Conformal 27 Fluorouracil 27 Cetuximab 26 Taxes 24 Rituximab 23 Irinotecan 23 1,2-diaminocyclohexaneplatinum II citrate 23 Radiation 21 merphos 20 Bevacizumab 19 Temozolomide 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Has results × osimertinib × Clear all

NCT03133546 2026-02-06

BOOSTER

ETOP IBCSG Partners Foundation

Phase 2 Completed

155 enrolled 23 charts

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡